Vascular access complications cause significant morbidity in end-stage renal disease (ESRD) patients, costing over $1 billion annually. Improving access strategies, particularly favoring radial arteriovenous fistulae, is crucial for reducing patient harm.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Discussion:
Key Insights:
Outlook: